Crescent Ventures Leads $10M Round for CrossBridge Bio

CE-Ventures, the venture capital arm of UAE-based Crescent Enterprises, and TMC Venture Fund have co-led a $10 million funding round for CrossBridge Bio, a Houston-based biotech firm, with participation from Portal Innovations, Alexandria Ventures, and Linden Lake Labs.

More to Know:

  • CrossBridge Bio was founded in 2023 by Michael Jason Torres.
  • The startup focuses on developing therapeutics, particularly for solid tumours.

 

 

 

 

 

مقالات ذات صلة

WideBot, an Egyptian AI company, has secured $3 million in a Pre-Series...

Startup: Proptech. Founding date: 2022. Country: Egypt. Investors: Beltone Venture Capital, CI...

Buildnow, Saudi’s “Build Now Pay Later” (BNPL) company, has raised $9.7 million...